Buzzing stock | Gufic Biosciences jumps 14%; here's why
Gufic Biosciences share price: Shares of Gufic Biosciences jumped over 14 percent on Tuesday. This was after the pharmaceutical company said that it has secured permission from Central Licensing Approving Authority, Central Drugs Standard Control Organisation, Ministry of Health and Family Welfare for the manufacture, sale and distribution of Isavuconazonium Sulfate API and finished formulation Isavuconazole for Injection 200 mg/vial.
Shares of Gufic Biosciences jumped over 14 percent on Tuesday. This was after the pharmaceutical company said that it has secured permission from Central Licensing Approving Authority, Central Drugs Standard Control Organisation, Ministry of Health and Family Welfare for the manufacture, sale and distribution of Isavuconazonium Sulfate API and finished formulation Isavuconazole for Injection 200 mg/vial.
Isavuconazole is indicated for the treatment of patients 18 years of age and older for the treatment of Invasive Aspergillosis and Invasive Mucormycosis.
Also Read |
Isavuconazole is a systemic antifungal drug of triazole class. The drug has already been approved by the US Food and Drug Administration on March 6, 2015, and European Medicines Agency on October 15, 2015.
Gufic Biosciences is engaged in the research and development, manufacturing, marketing, distribution and sale of pharmaceutical and allied products. The company is known and respected for innovative and high-quality pharmaceutical and herbal products along with a wide range of Active Pharmaceutical Ingredients.
At 11:28 am, shares of the pharmaceutical player gained 10.7 percent at Rs 274.45 on BSE. The scrip hit an all-time high at Rs 283.5 today.
The stock has gained after three days of consecutive losses.
First Published: Apr 12, 2022 12:16 PM IST
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
Lok Sabha Election 2024 — how regional parties are challenging national giants in Phase-4
May 15, 2024 6:17 AM
Supreme Court refuses plea seeking 6-year poll ban on PM
May 14, 2024 7:14 PM
Punjab Lok Sabha elections 2024: A look at BJP candidates
May 14, 2024 7:06 PM
Lok Sabha polls: EC disposes of 90% complaints related to MCC violations
May 14, 2024 4:45 PM